Clinical Trials for Acute Myeloid Leukemia With FLT3/ITD Mutation

Find clinical trials for acute myeloid leukemia with flt3/itd mutation. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML

NCT ID: NCT05024552

This clinical trial is studying a new combination treatment for patients with acute myeloid leukemia (AML) that has the FLT3 mutation and has either come back after treatment or did not respond to ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tampa, Florida, United States, Tampa, Florida, United States

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

NCT ID: NCT06222580

This clinical trial is studying two medications, SNDX-5613 and gilteritinib, to see if they can safely and effectively treat adults with a specific type of acute myeloid leukemia (AML) that has eit...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Columbus, Ohio, United States +1 more

A Study of XY0206 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory AML With FLT3-ITD-Mutation (ALIVE)

NCT ID: NCT05876832

The ALIVE clinical trial is studying a new treatment called XY0206 for patients with a type of blood cancer known as Acute Myeloid Leukemia (AML) that has a specific genetic mutation called FLT3-IT...

Not yet recruiting

Phase: PHASE3 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions